Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
12 June 2017Website:
http://myomo.comNext earnings report:
29 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 23:57:58 GMTDividend
Analysts recommendations
Institutional Ownership
MYO Latest News
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the official launch of the Myomo Academy, a comprehensive learning management system for professionals in Orthotics & Prosthetics (O&P) and Rehabilitation. The Myomo Academy is being launched during the 2024 AOPA (American Orthotic and Prosthe.
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, chairman and chief executive officer and David Henry, chief financial officer, will present and host one-on-one meetings with investors at the Sidoti Virtual Investor conference being held on June 12-13, 2024. Management's presentat.
Myomo, Inc. will release its financial results for the first quarter of 2024 on May 8, 2024, and will hold a conference call at 4:30 p.m. ET that same day with remarks by chairman and chief executive Paul R. Gudonis.
Medicare decision created a multi-decade revenue growth opportunity. Soft Q1 guidance due to non-recurring timing issues. 2024 guidance gives only partial-year credit to reimbursement change.
Myomo, Inc. (MYO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.29 per share a year ago.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Myomo, Inc. (MYO) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Market undervalues MYO stock due to poor understanding of CMS process. MYO is able to generate revenues in excess of $100mm/yr. MYO valuation gap will close before February 2024, when the final CMS price is published.
Myomo, Inc. (MYO) Q3 2023 Earnings Call Transcript
Myomo (NYSEMKT: MYO ) stock is dropping on Monday after the wearable medical robotics company priced a public share offering. A press release from Myomo highlights details of its planned public offering.
Myomo, Inc. (MYO) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.42 per share a year ago.
What type of business is Myomo?
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
What sector is Myomo in?
Myomo is in the Healthcare sector
What industry is Myomo in?
Myomo is in the Medical Devices industry
What country is Myomo from?
Myomo is headquartered in United States
When did Myomo go public?
Myomo initial public offering (IPO) was on 12 June 2017
What is Myomo website?
https://myomo.com
Is Myomo in the S&P 500?
No, Myomo is not included in the S&P 500 index
Is Myomo in the NASDAQ 100?
No, Myomo is not included in the NASDAQ 100 index
Is Myomo in the Dow Jones?
No, Myomo is not included in the Dow Jones index
When was Myomo the previous earnings report?
No data
When does Myomo earnings report?
The next expected earnings date for Myomo is 29 November 2024